Breaking News

Today
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
OPTN

Optinose

$11.03

0.05 (0.46%)

, SNY

Sanofi

$44.33

0.88 (2.03%)

07:56
10/17/18
10/17
07:56
10/17/18
07:56
Recommendations
Optinose, Sanofi, Regeneron analyst commentary at Jefferies »

Jefferies still sees…

OPTN

Optinose

$11.03

0.05 (0.46%)

SNY

Sanofi

$44.33

0.88 (2.03%)

REGN

Regeneron

$398.46

20.66 (5.47%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 19

    Oct

  • 20

    Oct

  • 23

    Oct

  • 28

    Oct

  • 29

    Oct

  • 06

    Nov

  • 28

    Jan

  • 22

    Mar

  • 28

    Apr

  • 13

    May

Yesterday
SNY

Sanofi

$44.27

0.815 (1.88%)

, LLY

Eli Lilly

$110.70

0.01 (0.01%)

15:43
10/16/18
10/16
15:43
10/16/18
15:43
Periodicals
Sanofi, Eli Lilly sued by Minnesota over insulin pricing, Reuters says »

Minnesota's attorney…

SNY

Sanofi

$44.27

0.815 (1.88%)

LLY

Eli Lilly

$110.70

0.01 (0.01%)

NVO

Novo Nordisk

$43.27

0.955 (2.26%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 19

    Oct

  • 19

    Oct

  • 20

    Oct

  • 23

    Oct

  • 28

    Oct

  • 29

    Oct

  • 06

    Nov

  • 07

    Nov

  • 28

    Jan

  • 22

    Mar

  • 28

    Apr

SNY

Sanofi

$44.33

0.875 (2.01%)

, NVO

Novo Nordisk

$43.28

0.965 (2.28%)

15:36
10/16/18
10/16
15:36
10/16/18
15:36
Periodicals
Drugmakers sued by Minnesota over insulin pricing, Bloomberg reports »

Bloomberg cites a lawsuit…

SNY

Sanofi

$44.33

0.875 (2.01%)

NVO

Novo Nordisk

$43.28

0.965 (2.28%)

LLY

Eli Lilly

$110.77

0.08 (0.07%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 19

    Oct

  • 19

    Oct

  • 20

    Oct

  • 23

    Oct

  • 28

    Oct

  • 29

    Oct

  • 06

    Nov

  • 07

    Nov

  • 28

    Jan

  • 22

    Mar

  • 28

    Apr

JNJ

Johnson & Johnson

$136.78

3.03 (2.27%)

, SNY

Sanofi

$44.14

0.69 (1.59%)

13:00
10/16/18
10/16
13:00
10/16/18
13:00
Recommendations
Johnson & Johnson, Sanofi, Roche, AstraZeneca, Pfizer, Eli Lilly, Merck, GlaxoSmithKline, Novartis, Bristol-Myers analyst commentary at Wells Fargo »

Drug price in ads not…

JNJ

Johnson & Johnson

$136.78

3.03 (2.27%)

SNY

Sanofi

$44.14

0.69 (1.59%)

RHHBY

Roche

$0.00

(0.00%)

AZN

AstraZeneca

$38.72

1.26 (3.36%)

PFE

Pfizer

$43.62

0.51 (1.18%)

LLY

Eli Lilly

$110.33

-0.36 (-0.33%)

MRK

Merck

$70.66

1.2 (1.73%)

GSK

GlaxoSmithKline

$39.61

0.74 (1.90%)

NVS

Novartis

$85.14

2 (2.41%)

BMY

Bristol-Myers

$57.62

0.03 (0.05%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 16

    Oct

  • 17

    Oct

  • 17

    Oct

  • 18

    Oct

  • 19

    Oct

  • 19

    Oct

  • 20

    Oct

  • 22

    Oct

  • 23

    Oct

  • 23

    Oct

  • 25

    Oct

  • 25

    Oct

  • 28

    Oct

  • 28

    Oct

  • 29

    Oct

  • 30

    Oct

  • 06

    Nov

  • 07

    Nov

  • 24

    Dec

  • 11

    Jan

  • 28

    Jan

  • 16

    Feb

  • 22

    Mar

  • 28

    Apr

PRNB

Principia Biopharma

$25.04

-0.05 (-0.20%)

, SNY

Sanofi

$43.45

0.56 (1.31%)

08:29
10/16/18
10/16
08:29
10/16/18
08:29
Hot Stocks
Principia Biopharma achieves additional $10M milestone from PRN2246 »

Principia Biopharma…

PRNB

Principia Biopharma

$25.04

-0.05 (-0.20%)

SNY

Sanofi

$43.45

0.56 (1.31%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 19

    Oct

  • 20

    Oct

  • 23

    Oct

  • 28

    Oct

  • 29

    Oct

  • 28

    Jan

  • 22

    Mar

  • 28

    Apr

SNY

Sanofi

$43.45

0.56 (1.31%)

08:06
10/16/18
10/16
08:06
10/16/18
08:06
Hot Stocks
Sanofi reports results from two Phase 3 trials evaluating Dupixent »

Two pivotal Phase 3…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 19

    Oct

  • 20

    Oct

  • 23

    Oct

  • 28

    Oct

  • 29

    Oct

  • 28

    Jan

  • 22

    Mar

  • 28

    Apr

JNJ

Johnson & Johnson

$133.75

-0.03 (-0.02%)

, SNY

Sanofi

$43.45

0.56 (1.31%)

06:10
10/16/18
10/16
06:10
10/16/18
06:10
Periodicals
Pharma pushes back against required listing of drug prices in TV ads, WSJ says »

The pharmaceutical…

JNJ

Johnson & Johnson

$133.75

-0.03 (-0.02%)

SNY

Sanofi

$43.45

0.56 (1.31%)

RHHBY

Roche

$0.00

(0.00%)

AZN

AstraZeneca

$37.46

0.31 (0.83%)

PFE

Pfizer

$43.11

-0.67 (-1.53%)

LLY

Eli Lilly

$110.69

0.2 (0.18%)

MRK

Merck

$69.46

-0.31 (-0.44%)

GSK

GlaxoSmithKline

$38.87

0.56 (1.46%)

NVS

Novartis

$83.14

0.37 (0.45%)

BMY

Bristol-Myers

$57.59

0.09 (0.16%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 16

    Oct

  • 17

    Oct

  • 17

    Oct

  • 18

    Oct

  • 19

    Oct

  • 19

    Oct

  • 20

    Oct

  • 22

    Oct

  • 23

    Oct

  • 23

    Oct

  • 25

    Oct

  • 25

    Oct

  • 28

    Oct

  • 28

    Oct

  • 29

    Oct

  • 30

    Oct

  • 06

    Nov

  • 07

    Nov

  • 24

    Dec

  • 11

    Jan

  • 28

    Jan

  • 16

    Feb

  • 22

    Mar

  • 28

    Apr

REGN

Regeneron

$377.80

-6.4 (-1.67%)

, SNY

Sanofi

$43.45

0.56 (1.31%)

05:30
10/16/18
10/16
05:30
10/16/18
05:30
Hot Stocks
Regeneron, Sanofi announce Phse 3 Dupixent trials met all endpoints »

Regeneron Pharmaceuticals…

REGN

Regeneron

$377.80

-6.4 (-1.67%)

SNY

Sanofi

$43.45

0.56 (1.31%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 19

    Oct

  • 20

    Oct

  • 23

    Oct

  • 28

    Oct

  • 29

    Oct

  • 06

    Nov

  • 28

    Jan

  • 22

    Mar

  • 28

    Apr

  • 13

    May

Monday
AIMT

Aimmune

$26.40

1.23 (4.89%)

, REGN

Regeneron

$384.20

12.47 (3.35%)

08:12
10/15/18
10/15
08:12
10/15/18
08:12
Hot Stocks
Aimmune Therapeutics announces initiation of Phase 2 study of AR101 »

Aimmune Therapeutics…

AIMT

Aimmune

$26.40

1.23 (4.89%)

REGN

Regeneron

$384.20

12.47 (3.35%)

SNY

Sanofi

$42.89

-0.83 (-1.90%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 19

    Oct

  • 20

    Oct

  • 23

    Oct

  • 28

    Oct

  • 29

    Oct

  • 06

    Nov

  • 28

    Jan

  • 22

    Mar

  • 28

    Apr

  • 13

    May

Saturday
AZN

AstraZeneca

$37.15

-0.49 (-1.30%)

, BMY

Bristol-Myers

$57.50

(0.00%)

07:04
10/13/18
10/13
07:04
10/13/18
07:04
Hot Stocks
Week in review: How Trump's policies moved stocks »

Catch up on the top…

AZN

AstraZeneca

$37.15

-0.49 (-1.30%)

BMY

Bristol-Myers

$57.50

(0.00%)

LLY

Eli Lilly

$110.49

2.54 (2.35%)

GSK

GlaxoSmithKline

$38.31

-0.17 (-0.44%)

JNJ

Johnson & Johnson

$133.78

-0.03 (-0.02%)

MRK

Merck

$69.77

1.41 (2.06%)

NVS

Novartis

$82.77

0.56 (0.68%)

PFE

Pfizer

$43.78

0.97 (2.27%)

RHHBY

Roche

$0.00

(0.00%)

SNY

Sanofi

$42.89

-0.83 (-1.90%)

NYT

New York Times

$24.98

0.145 (0.58%)

STMP

Stamps.com

$214.32

-0.43 (-0.20%)

AMZN

Amazon.com

$1,788.63

69.51 (4.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 16

    Oct

  • 16

    Oct

  • 16

    Oct

  • 17

    Oct

  • 17

    Oct

  • 19

    Oct

  • 19

    Oct

  • 20

    Oct

  • 22

    Oct

  • 23

    Oct

  • 23

    Oct

  • 25

    Oct

  • 25

    Oct

  • 25

    Oct

  • 28

    Oct

  • 28

    Oct

  • 29

    Oct

  • 30

    Oct

  • 06

    Nov

  • 07

    Nov

  • 24

    Dec

  • 11

    Jan

  • 28

    Jan

  • 16

    Feb

  • 22

    Mar

  • 28

    Apr

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.